PAR-25-103-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional). The purpose of this grant opportunity is to facilitate well-planned clinical trials across the cancer prevention and control spectrum, addressing gaps in information about the study population, accrual challenges, intervention, outcomes/endpoints, data/statistical challenges, or operational risks.

The funding opportunity is offered by the Department of Health and Human Services National Institutes of Health. The grant program falls under the Cancer Control (CFDA 93.399) federal grant program. Eligible applicant types include for-profit organizations, governmental entities, nonprofits, and educational institutions. The funding instrument is a cooperative agreement. The NOFO outlines the program description, objectives, and key details such as the solicitation number (PAR-25-103), application due dates, and award information. Preparatory studies funded through this opportunity are intended to improve trial design and feasibility, thereby saving time and resources for the National Cancer Institute.